Therefore, we investigated changes in the levels of DNMT1, DNMT3a, and DNMT3b, in addition to measuring DNA methylation, in the brain after severe cerebral ischemia and examined the effects of DNMT inhibitors on excitotoxic injury in cultured neuronal cell to define a therapeutic target. The gene discussed is DNMT1; the disease is brain ischemia.